Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,153Revenue $M481Net Margin (%)-31.6Altman Z-Score1.2
Enterprise Value $M2,217EPS $-2.3Operating Margin %-52.5Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.0Pre-tax Margin (%)-40.1Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %--Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %--Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-2,255.6ROA % (ttm)-7.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-16.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M69.4ROIC % (ttm)-21.4Gross Margin Increase y-yN

Gurus Latest Trades with MDCO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDCOVanguard Health Care Fund 2015-03-31 Add0.01%$24.32 - $31.29
($28.09)
$ 31.0010%Add 1.88%5,564,220
MDCOVanguard Health Care Fund 2014-12-31 Add0.04%$20.36 - $27.96
($24.81)
$ 31.0025%Add 14.67%5,461,430
MDCOJoel Greenblatt 2014-12-31 Sold Out -0.01%$20.36 - $27.96
($24.83)
$ 31.0025%Sold Out0
MDCOJoel Greenblatt 2014-09-30 Reduce-0.06%$22.95 - $29.64
($25.38)
$ 31.0022%Reduce -87.68%24,009
MDCOGeorge Soros 2014-09-30 Sold Out -0.02%$22.95 - $29.64
($25.38)
$ 31.0022%Sold Out0
MDCOVanguard Health Care Fund 2014-09-30 Add$22.32 - $29.64
($25.4)
$ 31.0022%Add 1.33%4,762,730
MDCOJoel Greenblatt 2014-06-30 Buy 0.07%$24.02 - $29.57
($26.67)
$ 31.0016%New holding194,954
MDCOGeorge Soros 2014-06-30 Buy 0.02%$24.02 - $29.57
($26.67)
$ 31.0016%New holding75,000
MDCOGeorge Soros 2014-03-31 Sold Out -0.02%$27.9 - $40.39
($33.35)
$ 31.00-7%Sold Out0
MDCOVanguard Health Care Fund 2014-03-31 Add0.01%$27.9 - $40.39
($33.09)
$ 31.00-6%Add 2.20%4,700,058
MDCOJoel Greenblatt 2014-03-31 Sold Out -0.01%$27.9 - $40.39
($33.35)
$ 31.00-7%Sold Out0
MDCOGeorge Soros 2013-12-31 Reduce-0.07%$31.48 - $38.91
($35.74)
$ 31.00-13%Reduce -80.00%50,000
MDCOVanguard Health Care Fund 2013-12-31 Add0.04%$31.48 - $38.91
($35.78)
$ 31.00-13%Add 8.20%4,599,069
MDCOJoel Greenblatt 2013-12-31 Buy 0.01%$31.48 - $38.91
($35.74)
$ 31.00-13%New holding13,990
MDCOVanguard Health Care Fund 2013-09-30 Add0.33%$29.68 - $34.54
($31.83)
$ 31.00-3%Add 219.22%4,250,415
MDCOGeorge Soros 2013-09-30 Add0.04%$29.68 - $34.54
($31.83)
$ 31.00-3%Add 66.67%250,000
MDCOVanguard Health Care Fund 2013-06-30 Add0.1%$30.76 - $37.1
($33.46)
$ 31.00-7%Add 181.56%1,331,500
MDCOGeorge Soros 2013-06-30 Add0.02%$30.76 - $37.1
($33.46)
$ 31.00-7%Add 57.89%150,000
MDCOVanguard Health Care Fund 2013-03-31 Buy 0.06%$23.97 - $33.41
($30.53)
$ 31.002%New holding472,900
MDCOGeorge Soros 2013-03-31 Buy 0.04%$23.97 - $33.41
($30.53)
$ 31.002%New holding95,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDCO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MDCO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Savage Robert G.Director 2015-11-13Sell5,000$39.34-21.2view
SBLENDORIO GLENNPresident & CFO 2015-09-03Sell25,000$42-26.19view
SBLENDORIO GLENNPresident & CFO 2015-08-31Sell114,495$39.75-22.01view
MEANWELL CLIVECEO 2015-08-31Sell49,998$39.36-21.24view
Spigelman Melvin KDirector 2015-08-31Sell20,000$40.5-23.46view
O'Connor William BernardSVP & Chief Acct. Officer 2015-08-31Sell35,451$40-22.5view
MEANWELL CLIVEChairman & CEO 2015-08-03Sell16,667$30.960.13view
MEANWELL CLIVEChairman & CEO 2015-07-01Sell16,667$28.399.19view
SBLENDORIO GLENNPresident & CFO 2015-06-25Sell3,305$32-3.13view
Shigeta HiroakiDirector 2015-06-08Sell7,500$28.996.93view

Quarterly/Annual Reports about MDCO:

News about MDCO:

Articles On GuruFocus.com
Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, Medicines Co Cangrelor Well-Recomm Apr 16 2015 
Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner Apr 25 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
George Soros' Top Buys in the Last Quarter Dec 23 2011 
George Soros Buys Amazon.com Inc., Motorola Solutions, Sandisk, Sells Ralph Lauren, Dendreon, Lawson Nov 15 2011 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 100,000 Shares Mar 01 2011 
Medicines Company Reports Operating Results (10-Q) Nov 09 2010 
Medicines Company Reports Operating Results (10-Q) May 10 2010 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 181,500 Shares May 04 2010 

More From Other Websites
The Medicines Company Announces Clive Meanwell, MD, PhD, Chief Executive Officer, Is the Recipient... Feb 05 2016
The Medicines Company to Announce Fourth Quarter and Full Year 2015 Financial Results on Wednesday,... Feb 04 2016
MEDICINES CO /DE Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in... Feb 03 2016
The Medicines Company Appoints Sarissa Capital Management Exec To Its Board Of Directors Feb 03 2016
The Medicines Company Appoints Alexander J. Denner, Ph.D. to its Board of Directors Feb 03 2016
The Medicines Company to Participate in Leerink Partners 5th Annual Global Healthcare Conference Feb 02 2016
The Medicines Company Completes Divestiture of its Hemostasis Portfolio to Mallinckrodt plc Feb 01 2016
John Paulson Puts Up Personal Holdings To Continue Longs In Greece, Puerto Rico & Mallinckrodt? Jan 26 2016
JPMorgan Reiterates Overweight On Medicines Co, Sees $50 Per Share On DCF Basis Jan 22 2016
Questionable Takeover Timing Jan 20 2016
Medicines Company Spikes On Report Of Possible Sale Jan 20 2016
Why Medicines (MDCO) Stock is Advancing Today Jan 20 2016
Drugmaker Medicines Co. Is Said to Explore a Sale Jan 20 2016
3 Top Jefferies Biotech Stocks to Buy for 2016 With Huge Upside Potential Jan 14 2016
The Medicines Company Advances Clinical Development of Investigational First-in-Class PCSK9... Jan 11 2016
The Medicines Company Advances Clinical Development of Investigational First-in-Class PCSK9... Jan 11 2016
12 Biotechs With Binary Events Coming This Year Jan 08 2016
Jefferies' Best Biotech Ideas For 2016 (And Beyond) Jan 06 2016
The Medicines Company to Participate in J.P. Morgan 34th Annual Healthcare Conference Jan 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK